Akebia Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Milestones
- Thursday, November 4, 2021, 7:17
- PR Newswire
- Add a comment
CAMBRIDGE, Mass., Nov. 4, 2021 /PRNewswire/ — Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today reported financial results for the third quarter ended September 30, 2021 and highlighted…
About the Author
admin has written 20652 stories on this site.